VanEck Pharmaceuticals ETF PPH Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
ETFs
USA
NASDAQ
VanEck Pharmaceuticals ETF (PPH)
VanEck Pharmaceuticals ETF (PPH) Financials

VanEck Pharmaceuticals ETF (PPH)

89.40

0.62

(0.70%)

Closed November 26 3:00PM

Delayed by 15 minutes

89.45

0.05

(0.06%)

After Hours: 6:59PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End September 29 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	2.115	2.249	1.603	-11.925	14.584	14.205	-12.567	17.949
Return on Equity (%)	2.155	2.339	1.643	-12.243	15.002	14.807	-13.723	19.358
Return on Invested Capital (%)	3976.389	2434.205	1443.192	1165.472	870.398	654.23	611.047	642.484
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	57.439	57.754	64.376	56.938	62.077	72.684	67.249	79.816
Earnings Per Share	1.458	1.225	1.075	-10.277	7.462	9.349	-7.424	17.134
Cash Per Share	N/A	0.015	0.017	N/A	0.047	0.038	0.091	0.05
Working Capital Per Share	0.059	0.053	0.088	0.094	0.15	0.199	0.199	0.217
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	3.052	2.41	2.172	-8.722	8.339	10.275	-6.549	18.804

Liquidity Ratios

Year End September 29 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	4.04M	4.94M	4.29M	2.49M	3.79M	4.39M	7.79M	5.39M

Key Stats and Ratios

Year End September 29 2023	Mar 2012
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	6.79M
Return on Assets (%)	N/A
Return on Equity (%)	N/A
Return on Invested Capital (%)	N/A
Operating Margin (%)	N/A
Net Profit Margin (%)	N/A
Sales Per Share	N/A
Book Value Per Share	N/A
Earnings Per Share	N/A
Cash Per Share	N/A
Working Capital Per Share	N/A
Operating Profit Per Share	N/A
EBIT Per Share	N/A
EBITDA Per Share	N/A
Free Cash Flow Per Share	N/A
Current Ratio	N/A
Quick Ratio	N/A
Inventory Turnover (Days)	N/A

Key Stats and Ratios

Market Cap	478.35M
Price to Earnings Ratio	5.22
Price to Sales Ratio	46.38
Price to Cash Ratio	1.8k
Price to Book Ratio	1.12
Dividend Yield	174.50%

Share Statistics

Shares Outstanding	5.39M
Average Volume (1 week)	257.66k
Average Volume (1 Month)	316.45k
52 Week Change	13.52%
52 Week High	99.51
52 Week Low	77.60

More Ratios Coming Soon!

VanEck Pharmaceuticals ETF

Southern Cross Payment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions